Optimizing the Drug-like Properties of Leads in Drug Discovery

Borchardt, Ronald (EDT); Kerns, Edward (EDT); Hageman, Michael (EDT); Thakker, Dhrien (EDT); Stevens, James (EDT)

ISBN 10: 1493950479 ISBN 13: 9781493950478
Editorial: Springer, 2016
Nuevos Encuadernación de tapa blanda

Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Vendedor de AbeBooks desde 6 de abril de 2009

Este artículo en concreto ya no está disponible.

Descripción

Descripción:

N° de ref. del artículo 28638968-n

Denunciar este artículo

Sinopsis:

This book arises from a workshop organized by the American Association of Pharmaceutical Scientists entitled "Optimizing the Drug-Like Properties of Leads in Drug Discovery," which took place in Parsippany, NJ in September 2004. The workshop focused on the optimization of the drug-like properties of leads in drug discovery. The volume outlines strategies and methodologies designed to guide pharmaceutical and biotechnology companies through the drug discovery and development process.

Reseña del editor:

This book arises from a workshop organized by the American Association of Pharmaceutical Scientists entitled "Optimizing the Drug-Like Properties of Leads in Drug Discovery," which took place in Parsippany, NJ in September 2004. The workshop focused on the optimization of the drug-like properties of leads in drug discovery. The volume outlines strategies and methodologies designed to guide pharmaceutical and biotechnology companies through the drug discovery and development process.

"Sobre este título" puede pertenecer a otra edición de este libro.

Detalles bibliográficos

Título: Optimizing the Drug-like Properties of Leads...
Editorial: Springer
Año de publicación: 2016
Encuadernación: Encuadernación de tapa blanda
Condición: New

Los mejores resultados en AbeBooks

Imagen del vendedor

Ronald Borchardt
Publicado por Springer New York Okt 2016, 2016
ISBN 10: 1493950479 ISBN 13: 9781493950478
Nuevo Taschenbuch
Impresión bajo demanda

Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book arises from a workshop organized by the American Association of Pharmaceutical Scientists entitled 'Optimizing the Drug-Like Properties of Leads in Drug Discovery,' which took place in Parsippany, NJ in September 2004. The workshop focused on the optimization of the drug-like properties of leads in drug discovery. The volume outlines strategies and methodologies designed to guide pharmaceutical and biotechnology companies through the drug discovery and development process. 524 pp. Englisch. Nº de ref. del artículo: 9781493950478

Contactar al vendedor

Comprar nuevo

EUR 213,99
Convertir moneda
Gastos de envío: EUR 23,00
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 2 disponibles

Añadir al carrito

Imagen del vendedor

Ronald Borchardt
ISBN 10: 1493950479 ISBN 13: 9781493950478
Nuevo Taschenbuch

Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Taschenbuch. Condición: Neu. Neuware -Drug discovery and development is a very complex, costly, and ti- consuming process. Because of the uncertainties associated with predicting the pharmacological effects and the toxicity characteristics of new chemical entities in man, their clinical development is quite prone to failure. In recent years, phar- ceutical companies have come under increasing pressure to introduce new blockbuster drugs into the marketplace more rapidly. Companies have responded to these pressures by introducing new technologies and new strategies to expedite drug discovery and development. Drug discovery and development have traditionally been divided into three separate processes (i. e. , discovery research, preclinical development, and clinical development) that ideally should be integrated both organizationally and functionally. Instead, separate and distinct discovery research, preclinical development, and clinical development divisions were created within many companies during the 1980s and 1990s, Because of their isolation, scientists in the discovery research divisions often were advancing drug candidates into preclinical development that had marginal drug-like properties. For the purpose of this presentation, ¿drug-like¿ properties refer to the molecule¿s physicochemical, absorption-distribution-metabolism-excretion (ADME), and toxicological properties. Lacking optimal drug-like properties often caused these drug candidates to fail in preclinical or clinical development.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 524 pp. Englisch. Nº de ref. del artículo: 9781493950478

Contactar al vendedor

Comprar nuevo

EUR 213,99
Convertir moneda
Gastos de envío: EUR 60,00
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 2 disponibles

Añadir al carrito

Imagen de archivo

Publicado por Springer, 2016
ISBN 10: 1493950479 ISBN 13: 9781493950478
Nuevo Tapa blanda

Librería: Ria Christie Collections, Uxbridge, Reino Unido

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Condición: New. In. Nº de ref. del artículo: ria9781493950478_new

Contactar al vendedor

Comprar nuevo

EUR 218,31
Convertir moneda
Gastos de envío: EUR 13,79
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: Más de 20 disponibles

Añadir al carrito

Imagen del vendedor

Ronald Borchardt
Publicado por Springer New York, Springer US, 2016
ISBN 10: 1493950479 ISBN 13: 9781493950478
Nuevo Taschenbuch

Librería: AHA-BUCH GmbH, Einbeck, Alemania

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Drug discovery and development is a very complex, costly, and ti- consuming process. Because of the uncertainties associated with predicting the pharmacological effects and the toxicity characteristics of new chemical entities in man, their clinical development is quite prone to failure. In recent years, phar- ceutical companies have come under increasing pressure to introduce new blockbuster drugs into the marketplace more rapidly. Companies have responded to these pressures by introducing new technologies and new strategies to expedite drug discovery and development. Drug discovery and development have traditionally been divided into three separate processes (i. e. , discovery research, preclinical development, and clinical development) that ideally should be integrated both organizationally and functionally. Instead, separate and distinct discovery research, preclinical development, and clinical development divisions were created within many companies during the 1980s and 1990s, Because of their isolation, scientists in the discovery research divisions often were advancing drug candidates into preclinical development that had marginal drug-like properties. For the purpose of this presentation, 'drug-like' properties refer to the molecule's physicochemical, absorption-distribution-metabolism-excretion (ADME), and toxicological properties. Lacking optimal drug-like properties often caused these drug candidates to fail in preclinical or clinical development. Nº de ref. del artículo: 9781493950478

Contactar al vendedor

Comprar nuevo

EUR 219,37
Convertir moneda
Gastos de envío: EUR 64,87
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 1 disponibles

Añadir al carrito

Imagen de archivo

Ronald Borchardt
ISBN 10: 1493950479 ISBN 13: 9781493950478
Nuevo Paperback

Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Paperback. Condición: new. Paperback. Drug discovery and development is a very complex, costly, and ti- consuming process. Because of the uncertainties associated with predicting the pharmacological effects and the toxicity characteristics of new chemical entities in man, their clinical development is quite prone to failure. In recent years, phar- ceutical companies have come under increasing pressure to introduce new blockbuster drugs into the marketplace more rapidly. Companies have responded to these pressures by introducing new technologies and new strategies to expedite drug discovery and development. Drug discovery and development have traditionally been divided into three separate processes (i. e. , discovery research, preclinical development, and clinical development) that ideally should be integrated both organizationally and functionally. Instead, separate and distinct discovery research, preclinical development, and clinical development divisions were created within many companies during the 1980s and 1990s, Because of their isolation, scientists in the discovery research divisions often were advancing drug candidates into preclinical development that had marginal drug-like properties. For the purpose of this presentation, drug-like properties refer to the molecules physicochemical, absorption-distribution-metabolism-excretion (ADME), and toxicological properties. Lacking optimal drug-like properties often caused these drug candidates to fail in preclinical or clinical development. This book arises from a workshop organized by the American Association of Pharmaceutical Scientists entitled "Optimizing the Drug-Like Properties of Leads in Drug Discovery," which took place in Parsippany, NJ in September 2004. The workshop focused on the optimization of the drug-like properties of leads in drug discovery. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Nº de ref. del artículo: 9781493950478

Contactar al vendedor

Comprar nuevo

EUR 233,41
Convertir moneda
Gastos de envío: GRATIS
A Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 1 disponibles

Añadir al carrito

Imagen de archivo

Publicado por Springer, 2016
ISBN 10: 1493950479 ISBN 13: 9781493950478
Nuevo Tapa blanda

Librería: Books Puddle, New York, NY, Estados Unidos de America

Calificación del vendedor: 4 de 5 estrellas Valoración 4 estrellas, Más información sobre las valoraciones de los vendedores

Condición: New. Nº de ref. del artículo: 26375274633

Contactar al vendedor

Comprar nuevo

EUR 261,15
Convertir moneda
Gastos de envío: EUR 3,43
A Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 4 disponibles

Añadir al carrito

Imagen de archivo

Publicado por Springer, 2016
ISBN 10: 1493950479 ISBN 13: 9781493950478
Nuevo Tapa blanda
Impresión bajo demanda

Librería: Majestic Books, Hounslow, Reino Unido

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Condición: New. Print on Demand. Nº de ref. del artículo: 371819350

Contactar al vendedor

Comprar nuevo

EUR 273,84
Convertir moneda
Gastos de envío: EUR 7,48
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 4 disponibles

Añadir al carrito

Imagen de archivo

Publicado por Springer, 2016
ISBN 10: 1493950479 ISBN 13: 9781493950478
Nuevo Tapa blanda
Impresión bajo demanda

Librería: Biblios, Frankfurt am main, HESSE, Alemania

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Condición: New. PRINT ON DEMAND. Nº de ref. del artículo: 18375274627

Contactar al vendedor

Comprar nuevo

EUR 279,75
Convertir moneda
Gastos de envío: EUR 9,95
De Alemania a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 4 disponibles

Añadir al carrito

Imagen de archivo

Ronald Borchardt
ISBN 10: 1493950479 ISBN 13: 9781493950478
Nuevo Paperback

Librería: AussieBookSeller, Truganina, VIC, Australia

Calificación del vendedor: 5 de 5 estrellas Valoración 5 estrellas, Más información sobre las valoraciones de los vendedores

Paperback. Condición: new. Paperback. Drug discovery and development is a very complex, costly, and ti- consuming process. Because of the uncertainties associated with predicting the pharmacological effects and the toxicity characteristics of new chemical entities in man, their clinical development is quite prone to failure. In recent years, phar- ceutical companies have come under increasing pressure to introduce new blockbuster drugs into the marketplace more rapidly. Companies have responded to these pressures by introducing new technologies and new strategies to expedite drug discovery and development. Drug discovery and development have traditionally been divided into three separate processes (i. e. , discovery research, preclinical development, and clinical development) that ideally should be integrated both organizationally and functionally. Instead, separate and distinct discovery research, preclinical development, and clinical development divisions were created within many companies during the 1980s and 1990s, Because of their isolation, scientists in the discovery research divisions often were advancing drug candidates into preclinical development that had marginal drug-like properties. For the purpose of this presentation, drug-like properties refer to the molecules physicochemical, absorption-distribution-metabolism-excretion (ADME), and toxicological properties. Lacking optimal drug-like properties often caused these drug candidates to fail in preclinical or clinical development. This book arises from a workshop organized by the American Association of Pharmaceutical Scientists entitled "Optimizing the Drug-Like Properties of Leads in Drug Discovery," which took place in Parsippany, NJ in September 2004. The workshop focused on the optimization of the drug-like properties of leads in drug discovery. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. Nº de ref. del artículo: 9781493950478

Contactar al vendedor

Comprar nuevo

EUR 374,66
Convertir moneda
Gastos de envío: EUR 31,77
De Australia a Estados Unidos de America
Destinos, gastos y plazos de envío

Cantidad disponible: 1 disponibles

Añadir al carrito